Non‐alcoholic fatty liver disease comorbid with major depressive disorder: the pathological features and poor therapeutic efficacy

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · see citing works

Diagnostic and Statistical Manual of Mental Disorders.

Widiger, T. A. (2000) · Oxford University Press eBooks · doi:10.1037/10518-009 · Cited by 19,767 · see citing works

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · see citing works

Nonalcoholic Fatty Liver Disease

Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228 · see citing works

Depression, chronic diseases, and decrements in health: results from the World Health Surveys

Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070 · see citing works

Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions

Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907 · see citing works

Nonalcoholic Steatohepatitis

Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903 · see citing works

Nonalcoholic Fatty Liver Disease

Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581 · see citing works

Association of depression and diabetes complications: a meta-analysis

de Groot, M., Anderson, R., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200107000-00015 · Cited by 1,799 · see citing works

Collaborative management to achieve treatment guidelines. Impact on depression in primary care

Katon, W. J. (1995) · JAMA · doi:10.1001/jama.273.13.1026 · Cited by 1,464 · see citing works

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., & Wing, R. R. (2010) · Hepatology · doi:10.1002/hep.23276 · Cited by 1,330 · see citing works

AGA technical review on nonalcoholic fatty liver disease

Sanyal, A. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36572 · Cited by 1,072 · see citing works

Prevalence and Effects of Mood Disorders on Work Performance in a Nationally Representative Sample of U.S. Workers

Kessler, R. C., Akiskal, H. S., Ames, M., Birnbaum, H., Greenberg, P., .A, R. M., Jin, R., Merikangas, K. R., Simon, G. E., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1561 · Cited by 868 · see citing works

Prevalence and Effects of Mood Disorders on Work Performance in a Nationally Representative Sample of U.S. Workers

Kessler, R. C., Akiskal, H. S., Ames, M., Birnbaum, H., Greenberg, P., .A, R. M., Jin, R., Merikangas, K. R., Simon, G. E., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.9.1561 · Cited by 868 · see citing works

Comorbid Depression is Associated With Increased Health Care Use and Expenditures in Individuals With Diabetes

Egede, L. E., Zheng, D., & Simpson, K. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.464 · Cited by 816 · see citing works

Impact of major depression on chronic medical illness

Katon, W., & Ciechanowski, P. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00313-6 · Cited by 485 · see citing works

Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century

Kessler, R. C., Merikangas, K. R., & Wang, P. S. (2007) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.3.022806.091444 · Cited by 468 · see citing works

The economic burden of depression and the cost-effectiveness of treatment

Wang, P. S., Simon, G., & Kessler, R. C. (2003) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.139 · Cited by 403 · see citing works

The Effectiveness of Depression Care Management on Diabetes-Related Outcomes in Older Patients

Williams, J., Katon, W., Lin, E., Noël, P., Worchel, J., Cornell, J., Harpole, L., Fultz, B. A., Hunkeler, E., Mika, V., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-12-200406150-00012 · Cited by 347 · see citing works

Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease

Youssef, N. A., Abdelmalek, M. F., Binks, M., Guy, C. D., Omenetti, A., Smith, A. D., Diehl, A. M. E., & Suzuki, A. (2013) · Liver International · doi:10.1111/liv.12165 · Cited by 182 · see citing works

Long-Term Effects on Medical Costs of Improving Depression Outcomes in Patients With Depression and Diabetes

Katon, W. J., Russo, J. E., Korff, M. V., Lin, E. H. B., Ludman, E. J., & Ciechanowski, P. S. (2008) · Diabetes Care · doi:10.2337/dc08-0032 · Cited by 174 · see citing works

On the Inseparability of Mental and Physical Health in Aged Persons Lessons From Depression and Medical Comorbidity

Katz, I. R. (1996) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199624410-00001 · Cited by 158 · see citing works

Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C

Weinstein, A. A., Kallman Price, J., Stepanova, M., Poms, L. W., Fang, Y., Moon, J., Nader, F., & Younossi, Z. M. (2011) · Psychosomatics · doi:10.1016/j.psym.2010.12.019 · Cited by 147 · see citing works

Natural history of nonalcoholic steatohepatitis.

Liou, I. W., & Kowdley, K. V. (2006) · PubMed · doi:10.1097/01.mcg.0000168644.23697.31 · Cited by 146 · see citing works

Readiness for behaviour change in non‐alcoholic fatty liver disease: implications for multidisciplinary care models

Stewart, K. E., Haller, D. L., Sargeant, C., Levenson, J. L., Puri, P., & Sanyal, A. J. (2014) · Liver International · doi:10.1111/liv.12483 · Cited by 68 · see citing works

Hepatocellular carcinoma with nonalcoholic steatohepatitis

Mori, S., Yamasaki, T., Sakaida, I., Takami, T., Sakaguchi, E., Kimura, T., Kurokawa, F., Maeyama, S., & Okita, K. (2004) · Journal of Gastroenterology · doi:10.1007/s00535-003-1308-3 · Cited by 66 · see citing works

Effect of Race/Ethnicity and Persistent Recognition of Depression on Mortality in Elderly Men With Type 2 Diabetes and Depression

Richardson, L., Egede, L. E., & Mueller, M. (2008) · Diabetes Care · doi:10.2337/dc07-2215 · Cited by 47 · see citing works

Restriction of calorie and iron intake results in reduction of visceral fat and serum alanine aminotransferase and ferritin levels in patients with chronic liver disease

Iwasa, M., Hara, N., Iwata, K., Ishidome, M., Sugimoto, R., Tanaka, H., Fujita, N., Kobayashi, Y., & Takei, Y. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00724.x · Cited by 26 · see citing works

Emerging drugs for non-alcoholic steatohepatitis

Tomeno, W., Yoneda, M., Imajo, K., Ogawa, Y., Kessoku, T., Saito, S., Eguchi, Y., & Nakajima, A. (2013) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2013.811232 · Cited by 15 · see citing works

Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver

Kaya, E., & Yilmaz, Y. N. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00178 · Cited by 230 · see citing works

Gut-derived systemic inflammation as a driver of depression in chronic liver disease

Kronsten, V. T., Tranah, T. H., Pariante, C. M., & Shawcross, D. L. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.11.008 · Cited by 134 · see citing works

Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression

Labenz, C., Huber, Y., Michel, M. S., Nagel, M., Galle, P. R., Kostev, K., & Schattenberg, J. M. (2020) · Hepatology Communications · doi:10.1002/hep4.1541 · Cited by 128 · see citing works

Depression and chronic liver diseases: are there shared underlying mechanisms?

Huang, X., Liu, X., & Yu, Y. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00134 · Cited by 121 · see citing works

Depression is associated with non‐alcoholic fatty liver disease among adults in the United States

Kim, D., Yoo, E. R., Li, A. A., Tighe, S. P., Cholankeril, G. T., Harrison, S. A., & Ahmed, A. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15395 · Cited by 102 · see citing works

Cognitive Changes and Brain Volume Reduction in Patients with Nonalcoholic Fatty Liver Disease

Filipović, B. F., Marković, O., Đurić, V., & Filipović, B. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/9638797 · Cited by 100 · see citing works

Depression and Cognitive Impairment—Extrahepatic Manifestations of NAFLD and NASH

Colognesi, M., Gabbia, D., & De Martin, S. (2020) · Biomedicines · doi:10.3390/biomedicines8070229 · Cited by 98 · see citing works

Is Fatty Liver Associated With Depression? A Meta-Analysis and Systematic Review on the Prevalence, Risk Factors, and Outcomes of Depression and Non-alcoholic Fatty Liver Disease

Xiao, J., Lim, L. K. E., Ng, C. H., Tan, D. J. H., Lim, W. H., Ho, C. S. H., Tan, E. X. X., Sanyal, A. J., & Muthiah, M. D. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.691696 · Cited by 94 · see citing works

Association between anxiety and depression and nonalcoholic fatty liver disease

Choi, J. M., Chung, G. E., Kang, S. J., Kwak, M.-S., Yang, J. I., Park, B., & Yim, J. Y. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.585618 · Cited by 68 · see citing works

Association between nonalcoholic fatty liver disease and depression: A systematic review and meta-analysis of observational studies

Gu, Y., Zhang, W., Hu, Y., Chen, Y., & Shi, J. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.12.128 · Cited by 66 · see citing works

Non-alcoholic fatty liver disease and coexisting depression, anxiety and/or stress in adults: a systematic review and meta-analysis

Shea, S., Lionis, C. D., Kite, C., Lagojda, L., Uthman, O. A., Dallaway, A., Atkinson, L., Chaggar, S. S., Randeva, H. S., & Kyrou, I. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1357664 · Cited by 65 · see citing works

Depression and increased risk of non-alcoholic fatty liver disease in individuals with obesity

Cho, I. Y., Chang, Y., Sung, E., Kang, J., Wild, S. H., Byrne, C. D., Shin, H. C., & Ryu, S. (2021) · Epidemiology and Psychiatric Sciences · doi:10.1017/s204579602000116x · Cited by 63 · see citing works

Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation

Cheon, S. Y., & Song, J. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00836-0 · Cited by 57 · see citing works

Association between depression and nonalcoholic fatty liver disease: Contributions of insulin resistance and inflammation

Lee, J. W., & Park, S. H. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.073 · Cited by 55 · see citing works

Depression and risk of gastrointestinal disorders: a comprehensive two-sample Mendelian randomization study of European ancestry

Chen, D., Zhang, Y., Huang, T., & Jia, J. (2023) · Psychological Medicine · doi:10.1017/s0033291723000867 · Cited by 52 · see citing works

Non-alcoholic fatty liver disease and its association with depression in Korean General Population

Jung, J. Y., Park, S. K., Oh, C.-M., Chung, P.-W., & Ryoo, J.-H. (2019) · Journal of Korean Medical Science · doi:10.3346/jkms.2019.34.e199 · Cited by 51 · see citing works

The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia

Jawad, M. Y., Meshkat, S., Tabassum, A., Mckenzie, A., Vincenzo, J. D. D., Guo, Z., Musavi, N. B., Phan, L., Ceban, F., Kwan, A. T. H., et al. (2022) · CNS Spectrums · doi:10.1017/s1092852922001043 · Cited by 48 · see citing works

Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines

Gangopadhyay, A., Ibrahim, R., Theberge, K., May, M. A., & Houseknecht, K. L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1042442 · Cited by 43 · see citing works

Complications of Non-Alcoholic Fatty Liver Disease in Extrahepatic Organs

Tomeno, W., Imajo, K., Takayanagi, T., Ebisawa, Y., Seita, K., Takimoto, T., Honda, K., Kobayashi, T., Nogami, A., Kato, T., et al. (2020) · Diagnostics · doi:10.3390/diagnostics10110912 · Cited by 42 · see citing works

Reduced brain activity in female patients with non-alcoholic fatty liver disease as measured by near-infrared spectroscopy

Takahashi, A., Kono, S., Wada, A., Oshima, S., Abe, K., Imaizumi, H., Fujita, M., Hayashi, M., Okai, K., Miura, I., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174169 · Cited by 36 · see citing works

Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study

Pfirrmann, D., Huber, Y., Schattenberg, J. M., & Simon, P. D. (2018) · Journal of Medical Internet Research · doi:10.2196/11250 · Cited by 33 · see citing works

Impaired learning and memory in rats induced by a high‐fat diet: Involvement with the imbalance of nesfatin‐1 abundance and copine 6 expression

Chen, Z., Xu, Y., Wu, R., Han, Y.-X., Yu, Y., Ge, J., & Chen, F. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12462 · Cited by 33 · see citing works

Association between depression and metabolic dysfunction-associated fatty liver disease/significant fibrosis

Kim, D., Dennis, B. B., Cholankeril, G. T., & Ahmed, A. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.02.101 · Cited by 31 · see citing works

Mobile App–Based Lifestyle Coaching Intervention for Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial

Kwon, O. Y., Lee, M. K., Lee, H. W., Kim, H., Lee, J. S., & Jang, Y. (2024) · Journal of Medical Internet Research · doi:10.2196/49839 · Cited by 32 · see citing works

Non-alcoholic fatty liver disease and neurological defects

Moretti, R., Caruso, P., & Gazzin, S. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2019.04.007 · Cited by 29 · see citing works

Impact of nonalcoholic fatty liver disease-related metabolic state on depression

Ntona, S., Papaefthymiou, A., Kountouras, J., Gialamprinou, D., Kotronis, G., Boziki, M. K., Pοlyzos, S. A., Tzitiridou‐Chatzopoulou, M., Chatzopoulos, D., Thavayogarajah, T., et al. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105484 · Cited by 28 · see citing works

Hepatic encephalopathy and depression in chronic liver disease: Is the common link systemic inflammation?

Kronsten, V. T., & Shawcross, D. L. (2022) · Analytical Biochemistry · doi:10.1016/j.ab.2021.114437 · Cited by 27 · see citing works

Inhibition of TREM‐1 attenuates inflammation and lipid accumulation in diet‐induced nonalcoholic fatty liver disease

Rao, S., Huang, J., Shen, Z., Xiang, C., Zhang, M., & Lu, X. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28468 · Cited by 27 · see citing works

A Behavioral Health Program for Alcohol Use Disorder, Substance Abuse, and Depression in Chronic Liver Disease

Verma, M., Horrow, J., & Navarro, V. (2019) · Hepatology Communications · doi:10.1002/hep4.1328 · Cited by 23 · see citing works

Reduced Quality of Life in Patients with Non-Alcoholic Fatty Liver Disease May Be Associated with Depression and Fatigue

Golubeva, J. A., Sheptulina, A. F., Yafarova, A. A., Мамутовна, М. Э., Kiselev, A. R., & Drapkina, O. M. (2022) · Healthcare · doi:10.3390/healthcare10091699 · Cited by 23 · see citing works

Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality

Ng, C. H., Xiao, J., Chew, N., Chin, Y. H., Chan, K. E., Quek, J., Lim, W. H., Tan, D. J. H., Loke, R. W. K., Tan, C., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.985803 · Cited by 25 · see citing works

Liver and inflammatory biomarker relationships to depression symptoms in healthy older adults

Savage, K. M., Porter, C., Bunnett, E. R., Hana, M., Keegan, A. P., Ogden, E., Stough, C. K. K., & Pipingas, A. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112186 · Cited by 25 · see citing works

Association of MTTP gene variants with pediatric NAFLD: A candidate-gene-based analysis of single nucleotide variations in obese children

Dai, D., Wen, F., Zhou, S., Su, Z., Liu, G., Wang, M., Zhou, J., & He, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185396 · Cited by 23 · see citing works

Psychological Biomarkers and Fibrosis: An Innovative Approach to Non-alcoholic Fatty Liver Disease

Funuyet‐Salas, J., Pérez-San-Gregorio, M. Á., Rodríguez, A. M., & Romero‐Gómez, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.585425 · Cited by 21 · see citing works

Nonalcoholic Fatty Liver Disease

Fitzpatrick, E. (2021) · Springer eBooks · doi:10.1007/978-3-030-80068-0_69 · Cited by 18 · see citing works

The association between serum albumin and depression in chronic liver disease may differ by liver histology

Cao, J., Qiu, W., Yu, Y., Li, N., Wu, H., & Chen, Z. (2022) · BMC Psychiatry · doi:10.1186/s12888-021-03647-8 · Cited by 18 · see citing works

Depression in nonalcoholic fatty liver disease and all-cause/cause-specific mortality

Kim, D., Manikat, R., Shaikh, A., Cholankeril, G., & Ahmed, A. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14087 · Cited by 17 · see citing works

Implementing sustainable liver health in Europe: a second EASL–Lancet Commission

Karlsen, T. H., Hutchinson, S. J., Zelber‐Sagi, S., Carrieri, P., Negro, F., Lim, A. G., Cecchini, M., Dirac, M. A., Murray, F., Engebretsen, E., et al. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00138-8 · Cited by 17 · see citing works

Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary Care

Yoneda, M., Kobayashi, T., Iwaki, M., Nogami, A., Saito, S., & Nakajima, A. (2023) · Gut and Liver · doi:10.5009/gnl220545 · Cited by 17 · see citing works

Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence?

Purssell, H., Whorwell, P. J., Athwal, V. S., & Vasant, D. H. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i12.1816 · Cited by 17 · see citing works

Causal relationship between depression and metabolic dysfunction-associated steatotic liver disease: a bidirectional Mendelian randomized study

Liang, W., Zhong, K., Lai, T., Zeng, Y., Huang, Z., Zhou, J., Huang, J., Shi, Z., Zhang, J., & Ding, F. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1384003 · Cited by 16 · see citing works

Persons with metabolic dysfunction‐associated steatotic liver disease are at increased risk of severe depression

Åström, H., Shang, Y., Hagström, H., & Wester, A. (2024) · Liver International · doi:10.1111/liv.16019 · Cited by 16 · see citing works

Fatty Liver and the Coronavirus Disease 2019 Pandemic: Health Behaviors, Social Factors, and Telemedicine Satisfaction in Vulnerable Populations

Kim, R. G., Medina, S. P., Magee, C., & Khalili, M. (2021) · Hepatology Communications · doi:10.1002/hep4.1873 · Cited by 15 · see citing works

Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism

Radford‐Smith, D. E., Patel, P. J., Irvine, K. M., Russell, A. W., Siskind, D. J., Anthony, D. C., Powell, E. E., & Probert, F. (2022) · PLoS ONE · doi:10.1371/journal.pone.0261555 · Cited by 15 · see citing works

Gegen Qinlian Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats via Oxidative Stress, Inflammation, and the NLRP3 Signal Axis

Ying, Y., Zhang, H., Yu, D., Zhang, W., Zhou, D., & Liu, S. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6659445 · Cited by 14 · see citing works

Interrelationship between physical activity and depression in nonalcoholic fatty liver disease

Weinstein, A. A., de Avila, L., Kannan, S., Paik, J. M., Golabi, P., Gerber, L. H., & Younossi, Z. M. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i3.612 · Cited by 14 · see citing works

Identification of an Immune-Neuroendocrine Biomarker Panel for Detection of Depression: A Joint Effects Statistical Approach

Chan, M. K., Cooper, J. D., Bot, M., Steiner, J. H., Penninx, B. W. J. H., & Bahn, S. (2015) · Neuroendocrinology · doi:10.1159/000442208 · Cited by 14 · see citing works

Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity

Brodosi, L., Stecchi, M., Musio, A., Bazzocchi, M., Risi, E., Marchignoli, F., Marchesini, G., & Petroni, M. L. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02287-0 · Cited by 13 · see citing works

Fatigue, depression, and sleep disorders are more prevalent in patients with metabolic-associated fatty liver diseases

Mostafa, A. M., Hafez, S. M., Abdullah, N. M., & Fouad, Y. M. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002752 · Cited by 12 · see citing works

Cross‐sectional study on stigma and motivation to adhere to lifestyle modification among vulnerable populations with fatty liver disease

Medina, S. P., Kim, R. G., Magee, C., Stapper, N., & Khalili, M. (2023) · Obesity Science & Practice · doi:10.1002/osp4.688 · Cited by 12 · see citing works

Non-alcoholic Fatty Liver Disease and Depression: Evidence for Genotype × Environment Interaction in Mexican Americans

Manusov, E. G., Diego, V. P., Sheikh, K., Laston, S., Blangero, J., & Williams‐Blangero, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.936052 · Cited by 11 · see citing works

Depression and hepatobiliary diseases: a bidirectional Mendelian randomization study

Kong, Y., Yao, Z., Ren, L., Zhou, L., Zhao, J., Qian, Y., & Lou, D. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1366509 · Cited by 13 · see citing works

Metabolic Associated Fatty Liver Disease as a Risk Factor for the Development of Central Nervous System Disorders

Yoshikawa, S., Taniguchi, K., Sawamura, H., Ikeda, Y., Asai, T. T., Tsuji, A., & Matsuda, S. (2023) · Livers · doi:10.3390/livers3010002 · Cited by 10 · see citing works

Causal relationships between neuropsychiatric disorders and nonalcoholic fatty liver disease: A bidirectional Mendelian randomization study

Wang, S., Gao, H., Lin, P., Qian, T., & Xu, L. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03386-6 · Cited by 10 · see citing works

Psychiatric Disorders and Their Treatment: Impact of Outcomes in Patients With Chronic Liver Disease

Holmes, R., Patel, A., & Desai, A. P. (2022) · Clinical Liver Disease · doi:10.1002/cld.1204 · Cited by 9 · see citing works

Psychological Biomarker Profile in NAFLD/NASH with Advanced Fibrosis

Funuyet‐Salas, J., Rodríguez, A. M., Conrad, R., & Pérez-San-Gregorio, M. Á. (2020) · Springer eBooks · doi:10.1007/978-3-030-37173-9_12 · Cited by 9 · see citing works

The Behavioral and Neuroinflammatory Impact of Ketamine in a Murine Model of Depression and Liver Damage

Mușat, M. I., Ifrim-Predoi, A.-M., Mitran, S. I., Osiac, E., & Cătălin, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083558 · Cited by 8 · see citing works

Hepatic Steatosis Aggravates Vascular Calcification via Extracellular Vesicle‐Mediated Osteochondrogenic Switch of Vascular Smooth Muscle Cells

Zeng, Z., Zhao, Z., Yuan, Q., Yang, S., Wang, Z., Zuo, W., Zeng, S., Li, A., Chen, Q., Zhu, G., et al. (2024) · Advanced Science · doi:10.1002/advs.202408660 · Cited by 7 · see citing works

Milk kefir drink may not reduce depression in patients with non-alcoholic fatty liver disease: secondary outcome analysis of a randomized, single-blinded, controlled clinical trial

Mohsenpour, M. A., Mohammadi, F., Razmjooei, N., Eftekhari, M. H., & Hejazi, N. (2023) · BMC Nutrition · doi:10.1186/s40795-023-00732-x · Cited by 9 · see citing works

Depressive symptom as a risk factor for cirrhosis in patients with primary biliary cholangitis: Analysis based on Lasso‐logistic regression and decision tree models

Zhou, S., Li, J., Liu, J., Dong, S., Chen, N., Ran, Y., Liu, H., Wang, X., Yang, H., Liu, M., et al. (2024) · Brain and Behavior · doi:10.1002/brb3.3639 · Cited by 7 · see citing works

Association between depression and liver function biomarkers among US cancer survivors in NHANES 2005–2020

Li, Y., Ye, Z., Ran, X., Luo, J., Li, H. Z., Zhou, P., Shen, S., & Li, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-78890-6 · Cited by 7 · see citing works

Pathophysiology of depression and anxiety in metabolic dysfunction-associated steatotic liver disease

Sampada, Naseem, M., Solanki, M., Sharma, R., Singh, C., & Sohal, A. (2025) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v16.i4.111029 · Cited by 6 · see citing works

Antioxidants in the Treatment of Chronic Diffuse Liver Diseases (the Results of the “MAXAR” Observational Program)

Mayevskaya, M. V., Ivashkin, V. T., Lunkov, V. D., Kryzhanovskiy, S. P., Pirogova, I. Y., Pavlov, C. S., Жаркова, М. С., Герович, Б. А., & Ma, M. (2018) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2018-28-5-77-97 · Cited by 6 · see citing works

Multipanel Approach including miRNAs, Inflammatory Markers, and Depressive Symptoms for Metabolic Dysfunction-Associated Steatotic Liver Disease Diagnosis during 2-Year Nutritional Intervention

Tobaruela-Resola, A. L., Riezu‐Boj, J. I., Milagro, F. I., Mogna-Peláez, P., Herrero, J. I., Elorz, M., Benito, A., Tur, J. A., Martínez, J. A., Abete, I., et al. (2024) · Nutrients · doi:10.3390/nu16111547 · Cited by 6 · see citing works

Promising new fixed combination for the treatment of diseases of the hepatobiliar system: Substantiation of pharmacotherapeutic properties and pharmaceutical quality profile

Bondarenko, L. B., GORCHAKOVA, N., Golembiovska, О., & Galkin, O. Y. (2018) · Regulatory Mechanisms in Biosystems · doi:10.15421/021804 · Cited by 5 · see citing works

Understanding susceptibility and targeting treatment in non-alcoholic fatty liver disease in children; moving the fulcrum

Fitzpatrick, E. (2019) · Proceedings of The Nutrition Society · doi:10.1017/s0029665118002914 · Cited by 5 · see citing works

Non-alcoholic fatty liver disease (NAFLD) and potential links to depression, anxiety, and chronic stress

Shea, S., Lionis, C., Kite, C., Atkinson, L., Chaggar, S. S., Randeva, H. S., & Kyrou, I. (2021) · Biomedicines · doi:10.3390/biomedicines9111697 · Cited by 4 · see citing works

An examination of eating behavior in patients with non-alcoholic fatty liver disease: A cross-sectional study in a Japanese population

Sugiyama, H., Kobayashi, Y., Wada, S., Ueda, M., Shima, T., Suzuki, T., Sumida, Y., Aoi, W., Naito, Y., & Kuwahata, M. (2022) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2022.200150 · Cited by 4 · see citing works

Development and validation of a predictive nomogram for the risk of MAFLD in postmenopausal women

Yang, M., Chen, X., Shen, Q., Xiong, Z., Liu, T., Leng, Y., & Jiao, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1334924 · Cited by 3 · see citing works

Presence of Mood and/or Anxiety Disorders Does Not Affect Success of Weight Management Therapies in Metabolic Dysfunction-Associated Steatotic Liver Disease

Bollinger, B., Cotter, R. J., Deng, Y., Ilagan‐Ying, Y. C., & Gupta, V. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08724-y · Cited by 3 · see citing works

V. Extrahepatic Manifestations: Cerebral and Cardiovascular Diseases, Chronic Kidney Disease

Imajo, K., Yoneda, M., & Nakajima, A. (2016) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.105.38 · Cited by 3 · see citing works

Psychosocial risks in metabolic dysfunction-associated steatotic liver disease

Åström, H., Lageborn, C. T., & Hagström, H. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2468297 · Cited by 3 · see citing works

Association between vitamin D status and depression in children with chronic liver disease

Behairy, O. G. A., Amer, A. A., Mansour, A. I., & Mohamed, K. I. (2020) · Egyptian Liver Journal · doi:10.1186/s43066-020-00042-y · Cited by 3 · see citing works

Gender differences in the associations of multiple psychiatric and chronic conditions with major depressive disorder among patients with opioid use disorder

Nwabueze, C., Elom, H., Liu, S. Z., Walter, S. M., Sha, Z., Acevedo, P., Ying Liu, Su, B., Xu, C. D., Piamjariyakul, U., et al. (2021) · Journal of Addictive Diseases · doi:10.1080/10550887.2021.1957639 · Cited by 3 · see citing works

Nonalcoholic Fatty Liver Disease

Fitzpatrick, E. (2015) · Springer eBooks · doi:10.1007/978-3-319-17169-2_66 · Cited by 3 · see citing works

Nonalcoholic Fatty Liver Disease

Fitzpatrick, E. (2022) · In clinical practice · doi:10.1007/978-3-030-98808-1_10 · Cited by 3 · see citing works

SERT-Deficient Mice Fed Western Diet Reveal Altered Metabolic and Pro-Inflammatory Responses of the Liver: A Link to Abnormal Behaviors

Cespuglio, R., Вячеславовна, Г. А., Zabegalov, K. N., Chaprov, K., Svirin, E. P., Sitdikova, K., Burova, A., Shulgin, B., Lebedeva, K., Deykin, A. V., et al. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl26778 · Cited by 2 · see citing works

Major Depression as a Catalyst for Nonalcoholic Fatty Liver Disease: Insights From a Comprehensive Mendelian Randomization Study

Su, Y., Lin, S., She, L., Xiong, J., Ding, Y., Zhang, Y., & Chen, Y. (2025) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/cjgh/6632867 · Cited by 2 · see citing works

The relationship between depression and non-alcoholic fatty liver disease: what is known today

Golubeva, Y. A., Sheptulina, A. F., & Drapkina, O. M. (2022) · Russian Journal of Evidence-Based Gastroenterology · doi:10.17116/dokgastro20221101120 · Cited by 2 · see citing works

Differential Expression of Lipid Metabolism Genes, CROT and ABCG1, in Obese Patients with Comorbid Depressive Disorder and Risk of MASLD

Jurek, J. M., Rusu, E. C., Camaron, J., Clavero-Mestres, H., Aguilar, C., Riesco, D., Xifré, B., Chicote, J. U., Martínez, S., Vives, M., et al. (2025) · Metabolites · doi:10.3390/metabo15060392 · Cited by 2 · see citing works

Genotype-by-Environment Interactions in Nonalcoholic Fatty Liver Disease and Chronic Illness among Mexican Americans: The Role of Acculturation Stress

Manusov, E. G., Diego, V. P., Almeida, M., Ortiz, D., Curran, J. E., Galan, J. A., Leandro, A. C., Laston, S., Blangero, J., & Williams‐Blangero, S. (2024) · Genes · doi:10.3390/genes15081006 · Cited by 2 · see citing works

The effect of zinc supplementation on mental health in overweight/obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial

Fathi, M., Alavine­jad, P., Haidari, Z., & Amani, R. (2022) · Journal of Trace Elements and Minerals · doi:10.1016/j.jtemin.2022.100035 · Cited by 1 · see citing works

Reducing complications of metabolic dysfunction–associated steatotic liver disease

Wada, N., Iwaki, M., Kobayashi, T., Nakajima, A., & Yoneda, M. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2502549 · Cited by 1 · see citing works

Clinical Outcomes Following a Patient-Centered Educational Intervention on Steatotic Liver Disease: A Comparison of Patients With and Without Diabetes

Kim, R. G., Patel, S. A., Shui, A. M., Magee, C., Chen, J. Y., Tana, M. M.-S., & Khalili, M. (2025) · Gastro Hep Advances · doi:10.1016/j.gastha.2025.100710 · Cited by 1 · see citing works

Relationship between depression and chronic liver disease: Potential role of antidepressants in modulating liver fibrosis

Nasir, A. B., Zouridis, S., Aspichueta, P., Manka, P. P., & Syn, W. (2025) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2025.07.018 · Cited by 1 · see citing works

Incidence of Metabolic Dysfunction-Associated Steatotic Liver Disease After Developing Depression: A Population-Based Cohort Study

Kim, E., Sohn, W., Kim, Y. T., Oh, K., Shin, Y. C., Jeon, S. W., Shin, D., Kim, J., Yon, D. K., & Cho, S. J. (2025) · Journal of Korean Medical Science · doi:10.3346/jkms.2026.41.e6 · Cited by 1 · see citing works

Effects of Hydro‐Ethanolic Extract of Portulaca oleracea (Purslane) on Depression, Anxiety, and Stress Symptoms in Patients With Non‐Alcoholic Fatty Liver Disease: A Randomized Double‐Blind Controlled Trial

Milkarizi, N., Barghchi, H., Nematizade, M., Belyani, S., Bahari, H., Rajabzade, F., Kheyrabadi, S. Y. G., Razavidarmian, M., & Nematy, M. (2026) · Health Science Reports · doi:10.1002/hsr2.72681 · Cited by 1 · see citing works

Patient counseling for chronic liver disease patients with anxiety and depression: A cross-sectional study

Mugada, V., Veera, K. C., & Paravada, J. (2020) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2020.104010 · Cited by 1 · see citing works

Psychosomatik der nichtalkoholischen Fettleber

Vogel, M., Plauschin, K., & Frommer, J. (2022) · Springer eBooks · doi:10.1007/978-3-662-62484-5_17 · Cited by 1 · see citing works

Pharmacological Interventions in Older Adults

Patel, J. J., Smith, D. W., Heafner, J., Christopher, N. G., & Grossberg, G. T. (2019) · Springer eBooks · doi:10.1007/978-3-030-10814-4_9

FKBP51 levels negatively correlate with Depressive symptoms in Chronic Hepatitis CPreprint

Pham, A. D., Wong, D. J., Yeoh, S. W., Lewis, D., Lee, T. T., Mostaid, M. S., Chana, G., Bousman, C., Holmes, A., Saling, M. M., et al. (2020) · medRxiv · doi:10.1101/2020.03.19.20039248

Depression and non-alcoholic fatty liver disease: Association and potential mechanisms

Peng, H.-L., Liu, L., Liu, D., & Tan, Y. (2022) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v30.i7.295

Psychological Burden of NAFLD and Psychiatric Disorders as Extrahepatic Manifestations

Petrea, O. C., Ștefănescu, G., & Ștefănescu, C. (2023) · Springer eBooks · doi:10.1007/978-3-031-33548-8_18

El estrés psicosocial en la esteatosis hepática asociada a disfunción metabólica (MASLD): sobreposición desfavorable

Aleman, L., Dufeu, M. S., Catalina Fuenzalida, R., Ortiz‐López, N., Pinto-León, A., Daniela Simian, M., Gonzalo Cárdenas, L., Cristián Garrido, I., Máximo Cattaneo, B., Urzua, A. M., et al. (2024) · Revista Hospital Clínico Universidad de Chile · doi:10.5354/2735-7996.2024.74638

Differential Expression of Lipid Metabolism Genes, CROT and ABCG1, in Patients with MASLD Risk and Comorbid Depressive DisorderPreprint

Jurek, J. M., Rusu, E. E., Camaron, J., Clavero-Mestres, H., Aguilar, C., Riesco, D., Xifré, B., Chicote, J. U., Martínez, S., Vives, M., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5037466

Highlighting the relevance of a multidisciplinary approach in metabolic-asociated steatotic liver disease (MASLD)

Lara‐Romero, C., Fernández-Gómez, M. A., Martı́n, F., Castilla‐Guerra, L., Funuyet‐Salas, J., Berná, G., Millán-Domínguez, R., & Romero‐Gómez, M. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2584022

Association between steatotic liver disease and post-traumatic stress symptoms in the Fukushima health management survey

Hayashi, F., Ohira, T., Takahashi, A., Ueda, Y., Nakano, H., Okazaki, K., Nagao, M., Sato, S., Maeda, M., Miura, I., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-41265-0

Anxiety and depression in liver disease: Pathways, prevalence, and implications for care

Carrieri, P., Leonhard, A., Karlsen, T. H., Rutter, H., Fabrellas, N., Burra, P., Zelber‐Sagi, S., & Schomerus, G. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.102024 · Cited by 1 · see citing works

Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality

Ng, C. H., Xiao, J., Chew, N., Chin, Y. H., Chan, K. E., Quek, J., Lim, W. H., Tan, D. J. H., Loke, R. W. K., Tan, C., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.985803 · Cited by 25 · see citing works

Depression is associated with non‐alcoholic fatty liver disease among adults in the United States

Kim, D., Yoo, E. R., Li, A. A., Tighe, S. P., Cholankeril, G. T., Harrison, S. A., & Ahmed, A. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15395 · Cited by 102 · see citing works

Exploring the link between non-alcoholic fatty liver disease and depression: a systematic review and meta-analysis of bidirectional risk

Mou, L. (2025) · American Journal of Translational Research · doi:10.62347/xlva5738 · Cited by 6 · see citing works

Frequency of depression in patients with non-alcoholic fatty liver disease

Bashir, T., Shafi, A., & Khalil, F. (2020) · Journal of Fatima Jinnah Medical University

Is Fatty Liver Associated With Depression? A Meta-Analysis and Systematic Review on the Prevalence, Risk Factors, and Outcomes of Depression and Non-alcoholic Fatty Liver Disease

Xiao, J., Lim, L. K. E., Ng, C. H., Tan, D. J. H., Lim, W. H., Ho, C. S. H., Tan, E. X. X., Sanyal, A. J., & Muthiah, M. D. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.691696 · Cited by 94 · see citing works